Literature DB >> 9420716

Prognostic value of myocardial hypoperfusion indexes in patients with suspected or known coronary artery disease.

M Petretta1, A Cuocolo, A Carpinelli, E Nicolai, G Valva, V Bianchi, L Salemme, M Salvatore, D Bonaduce.   

Abstract

BACKGROUND: We evaluated the prognostic value of exercise 201Tl indexes of myocardial hypoperfusion in patients with suspected or known coronary artery disease. METHODS AND
RESULTS: Patients were divided into two groups: group I consisted of 332 patients with diagnostic electrocardiographic stress test results and group II consisted of 144 patients with nondiagnostic (inadequate or uninterpretable) stress electrocardiograms. At the 2-year follow-up, 20 hard events (16 cardiac deaths and 4 nonfatal myocardial infarctions) and 80 soft events (coronary revascularization procedures) occurred in group I. Considering total events, thallium imaging provided significant prognostic information in addition to clinical and exercise stress test data in the total study population (p < 0.001) and in patients with previous myocardial infarction (p < 0.001); in patients without previous infarction, thallium imaging added incremental prognostic value only in those with positive electrocardiographic stress test results (p < 0.01). When only hard events were considered, thallium variables added further information only in patients with previous myocardial infarction (p < 0.05). In group II at the end of follow-up, 15 hard and 39 soft events had occurred. In these patients occurrence of total (p < 0.001), hard (p < 0.05), and soft (p < 0.001) events was higher in those with abnormal thallium scintigraphic results than in those without. Moreover, no clinical and exercise variable, except history of myocardial infarction, was significantly related to outcome, whereas both indexes of extent and severity of hypoperfusion were significant.
CONCLUSIONS: The results of this study demonstrate that scintigraphic indexes of myocardial hypoperfusion obtained by qualitative planar thallium imaging give unique prognostic information in patients with nondiagnostic electrocardiographic stress test results. Thallium imaging provides incremental prognostic information even in patients with diagnostic electrocardiographic stress test results but not in the low-risk subset of patients without previous infarction who have negative electrocardiographic stress test results.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 9420716     DOI: 10.1007/bf02939954

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  38 in total

1.  Independent and incremental prognostic value of tests performed in hierarchical order to evaluate patients with suspected coronary artery disease. Validation of models based on these tests.

Authors:  S G Pollock; R D Abbott; C A Boucher; G A Beller; S Kaul
Journal:  Circulation       Date:  1992-01       Impact factor: 29.690

2.  Acute myocardial infarction associated with single vessel coronary artery disease: an analysis of clinical outcome and the prognostic importance of vessel patency and residual ischemic myocardium.

Authors:  W W Wilson; R S Gibson; T W Nygaard; G B Craddock; D D Watson; R S Crampton; G A Beller
Journal:  J Am Coll Cardiol       Date:  1988-02       Impact factor: 24.094

Review 3.  Exercise radionuclide imaging approaches to coronary artery disease.

Authors:  R D Okada; C A Boucher; H W Strauss; G M Pohost
Journal:  Am J Cardiol       Date:  1980-12-18       Impact factor: 2.778

4.  Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease.

Authors:  A S Iskandrian; S C Chae; J Heo; C D Stanberry; V Wasserleben; V Cave
Journal:  J Am Coll Cardiol       Date:  1993-09       Impact factor: 24.094

5.  Prediction of cardiac events after uncomplicated myocardial infarction: a prospective study comparing predischarge exercise thallium-201 scintigraphy and coronary angiography.

Authors:  R S Gibson; D D Watson; G B Craddock; R S Crampton; D L Kaiser; M J Denny; G A Beller
Journal:  Circulation       Date:  1983-08       Impact factor: 29.690

6.  Exercise thallium-201 scintigraphy and prognosis in typical angina pectoris and negative exercise electrocardiography.

Authors:  C N Bairey; A Rozanski; J Maddahi; K J Resser; D S Berman
Journal:  Am J Cardiol       Date:  1989-08-01       Impact factor: 2.778

7.  Exercise thallium-201 scintigraphy in men with nondiagnostic exercise electrocardiograms. Prognostic implications.

Authors:  A S Iskandrian; A H Hakki; S Kane-Marsch
Journal:  Arch Intern Med       Date:  1986-11

8.  Prognostic value of exercise thallium-201 imaging in patients presenting for evaluation of chest pain.

Authors:  K A Brown; C A Boucher; R D Okada; T E Guiney; J B Newell; H W Strauss; G M Pohost
Journal:  J Am Coll Cardiol       Date:  1983-04       Impact factor: 24.094

9.  Comparison of thallium redistribution with rest "reinjection" imaging for the detection of viable myocardium.

Authors:  T P Rocco; V Dilsizian; K A McKusick; A J Fischman; C A Boucher; H W Strauss
Journal:  Am J Cardiol       Date:  1990-07-15       Impact factor: 2.778

10.  Prediction of multivessel coronary artery disease and prognosis early after acute myocardial infarction by exercise electrocardiography and thallium-201 myocardial perfusion scanning.

Authors:  R D Abraham; S B Freedman; R F Dunn; H Newman; G S Roubin; P J Harris; D T Kelly
Journal:  Am J Cardiol       Date:  1986-09-01       Impact factor: 2.778

View more
  2 in total

Review 1.  An overview of radiotracers in nuclear cardiology.

Authors:  W Acampa; C Di Benedetto; A Cuocolo
Journal:  J Nucl Cardiol       Date:  2000 Nov-Dec       Impact factor: 5.952

2.  Prognostic value of coronary angiography in patients with chronic ischemic left ventricular dysfunction and evidence of viable myocardium on thallium reinjection imaging.

Authors:  M Petretta; A Cuocolo; D Bonaduce; E Nicolai; M L Vicario; M Salvatore
Journal:  J Nucl Cardiol       Date:  1997 Sep-Oct       Impact factor: 5.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.